113 related articles for article (PubMed ID: 3757883)
1. [Immunochemical study of antigens in the ascitic fluid of patients with ovarian cancer].
Sergeeva NS; Vasil'ev MIu; Avdeev GI
Eksp Onkol; 1986; 8(4):37-40. PubMed ID: 3757883
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of one of ascitic fluid antigens in patients with ovarian cancer using normal and tumor tissues].
Sergeeva NS; Vasil'ev MIu; Sokolova NV; Avdeev GI
Eksp Onkol; 1988; 10(1):20-2. PubMed ID: 3131099
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of one of the ascitic fluid antigens of ovarian cancer patients in malignant tumors of the stomach and intestines].
Sergeeva NS; Vasil'ev MIu; Kovalenko TI; Sokolova NV; Avdeev GI
Eksp Onkol; 1989; 11(2):35-7. PubMed ID: 2661204
[TBL] [Abstract][Full Text] [Related]
4. Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.
Rao GS; Hanjani P
Obstet Gynecol; 1988 Mar; 71(3 Pt 1):423-8. PubMed ID: 3279355
[TBL] [Abstract][Full Text] [Related]
5. [Immunochemical identification of onco-ovarian acid-soluble alpha-2-globulin].
Prokopenko PG; Borisenko SA; Makarov OV; Tatarinov IuS
Biull Eksp Biol Med; 1991 Aug; 112(8):185-8. PubMed ID: 1723903
[TBL] [Abstract][Full Text] [Related]
6. [Immunochemical identification of beta2-globulin in metastases of ovarian tumors].
Prokopenko PG; Borisenko SA; Tatarinov IuS
Biull Eksp Biol Med; 1988 Jul; 106(7):81-3. PubMed ID: 3042035
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
[No Abstract] [Full Text] [Related]
8. [Immunochemical identification of a new embryonal antigen in ovarian tumor tissue].
Kalashnikov VV; Borisenko SA; Tatarinov IS
Biull Eksp Biol Med; 1976 Jun; 81(6):725-6. PubMed ID: 953311
[TBL] [Abstract][Full Text] [Related]
9. [Comments on the paper by Schröck et al., The simultaneous determination of Ca 125 and D-dimer in plasma and ascitic fluid in ovarian cancer].
Mezger J
Onkologie; 1986 Feb; 9(1):10. PubMed ID: 3523340
[No Abstract] [Full Text] [Related]
10. An immunomagnetic-based method for the purification of ovarian cancer cells from patient-derived ascites.
Barker SD; Casado E; Gomez-Navarro J; Xiang J; Arafat W; Mahasreshti P; Pustilnik TB; Hemminki A; Siegal GP; Alvarez RD; Curiel DT
Gynecol Oncol; 2001 Jul; 82(1):57-63. PubMed ID: 11426962
[TBL] [Abstract][Full Text] [Related]
11. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
12. Early diagnosis of ovarian cancer.
Popkin DR
Can Med Assoc J; 1979 May; 120(9):1106-8. PubMed ID: 445304
[TBL] [Abstract][Full Text] [Related]
13. [Organ-specific intestinal antigens contained in tumors of the human gastrointestinal tract].
Pugachev KK; Vasil'ev MIu; Avdeev GI
Eksp Onkol; 1986; 8(2):45-8. PubMed ID: 3084194
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
15. An ovarian cancer-associated antigen that crossreacts with a pregnancy-associated protein.
Nakai M; Ohsawa Y; Nagata E; Arai M
Eur J Obstet Gynecol Reprod Biol; 1987 Jan; 24(1):39-48. PubMed ID: 2434369
[TBL] [Abstract][Full Text] [Related]
16. Identification of an ectopic developmental antigen that appears in malignant ascitic fluid.
Nakai M; Ishikawa M; Kawauchi H
Eur J Obstet Gynecol Reprod Biol; 1991 Nov; 42(1):61-9. PubMed ID: 1663874
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
18. The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.
Qian HN; Feng J; Fu TY
Gynecol Oncol; 1985 Jan; 20(1):100-8. PubMed ID: 3965372
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90K.
Zeimet AG; Stadlmann S; Natoli C; Widschwendter M; Hermann M; Abendstein B; Daxenbichler G; Offner FA; Iacobelli S; Marth C
Anticancer Res; 2000; 20(6B):4507-11. PubMed ID: 11205296
[TBL] [Abstract][Full Text] [Related]
20. Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.
Rao GS; Hanjani P
Am J Obstet Gynecol; 1988 Jul; 159(1):94-8. PubMed ID: 3394756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
